Displaying 2 (all) recruiting clinical trials.
-
Paroxysmal nocturnal hemoglobinuria (PNH) Registry
This is a non interventional registry to gather information on the clinical presentation and outcomes of patients with PNH. The PHN Registry will capture post-marketing ... -
A phase 4 single-arm open-label clinical study of pembrolizumab (MK-3475) to evaluate the efficacy and safety of MK-3475 plus carboplatin and paclitaxel as first-line treatment of recurrent/ metastatic head and neck squamous cell carcinoma.
The purpose of the study is to evaluate the safety, efficacy, and tolerability of combined treatment: pembrolizumab and carboplatin and paclitaxel for patients with recurrent ...